Prelude Capital Management, LLC Bristol Myers Squibb CO Put Options Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.78 Million - $2 Million	30,000 New	30,000 $1.89 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $98,676 - $115,362	-1,800 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $2.51 Million - $3.64 Million	-54,000 Reduced 96.77%	1,800 $100,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $19,684 - $25,676	400 Added 0.72%	55,800 $3.58 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.09 Million - $1.29 Million	25,400 Added 84.67%	55,400 $2.81 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.12 Million - $1.23 Million	25,000 Added 500.0%	30,000 $1.36 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $3.16 Million - $3.77 Million	-70,000 Reduced 93.33%	5,000 $239,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $4.14 Million - $4.67 Million	75,000 New	75,000 $4.66 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.